Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis Inc
(NQ:
PSNL
)
5.800
-0.170 (-2.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis Inc
< Previous
1
2
3
4
5
6
7
Next >
Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance
October 18, 2023
From
Personalis, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
Friday's session saw 112 companies set new 52-week lows.
Via
Benzinga
Analyst Ratings for Personalis
May 04, 2023
Via
Benzinga
Recap: Personalis Q1 Earnings
May 03, 2023
Via
Benzinga
Personalis's Return On Capital Employed Insights
February 28, 2023
Via
Benzinga
Earnings Outlook For Personalis
February 22, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
August 29, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 24, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at Upcoming Investor Conferences
August 01, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Second Quarter 2023 Financial Results
July 25, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics
June 26, 2023
From
Personalis, Inc.
Via
Business Wire
Dr. Kenneth J. Widder Joins Personalis Board of Directors
June 13, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023
May 30, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
May 16, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Reports First Quarter 2023 Financial Results
May 03, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer
May 02, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce First Quarter 2023 Financial Results
April 19, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
April 05, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
March 22, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay
March 07, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis Appoints Christopher Hall as Chief Executive Officer
March 02, 2023
From
Personalis, Inc.
Via
Business Wire
Toll Brothers To Rally 25%? Here Are 10 Other Analyst Forecasts For Friday
February 24, 2023
Oppenheimer boosted the price target for Universal Display Corporation (NASDAQ: OLED) from $150 to $160. Oppenheimer analyst Martin Yang maintained an Outperform rating on the stock. Universal Display...
Via
Benzinga
Personalis Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Fourth Quarter and Full Year 2022 Financial Results
February 09, 2023
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Personalis to Participate at Upcoming Investor Conferences
February 06, 2023
From
Personalis, Inc.
Via
Business Wire
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.